Other substances

Aminoglutethimide

An aromatase inhibitor.

Phase of research

Potential treatment - theoretical effect

How it helps

Antiviral

Drug status

Used to treat other disease

1
 Supporting references
0
 Contradictory references
1
 AI-suggested references
0
 Clinical trials

General information

Aminoglutethimide on DrugBank
Aminoglutethimide on PubChem

Marketed as

CYTADREN

 

Structure image - Aminoglutethimide

CCC1(CCC(=O)NC1=O)C2=CC=C(C=C2)N

Supporting references

Link Tested on Impact factor Notes Publication date
Inhibition of SARS-CoV-2 main protease 3CLpro by means of α-ketoamide and pyridone-containing pharmaceuticals using in silico molecular docking
3CLpro Small molecule In silico 		in silico 2.46

Predicted to inhibit the SARS-CoV-2 3C-like protease.

 Jul/10/2020

AI-suggested references

Link Publication date
Inhibition of SARS-CoV-2 main protease 3CLpro by means of alpha-ketoamide and pyridone-containing pharmaceuticals using in silico molecular docking.
Jul/10/2020
Export (.csv)